Astellas Partners with Dyno Therapeutics for Gene Therapy Technology

By Lucy Haggerty

Pharma Deals Review: Vol 2021 Issue 12 (Table of Contents)

Published: 9 Dec-2021

DOI: 10.3833/pdr.v2021.i12.2649     ISSN: 1756-7874

Section: Licensing



In order to strengthen its gene therapy pipeline, Astellas Pharma has agreed to pay US$18 M upfront and committed up to US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details